Literature DB >> 9398038

Dietary fat intake and risk of prostate cancer: a prospective study of 25,708 Norwegian men.

M B Veierød1, P Laake, D S Thelle.   

Abstract

The relationship between incidence of prostate cancer and intake of dietary fat and foods rich in fat was studied in 25,708 men aged 16-56 years attending a Norwegian health screening in 1977-1983. Linkage to the Cancer Registry of Norway and the Central Bureau of Statistics of Norway ensured a complete follow-up until December 31, 1992. Diet was recorded on a semi-quantitative food-frequency questionnaire at the time of screening, and 72 cases of prostate cancer were identified during follow-up. At the end of follow-up, mean age of the total study sample was 56 years (range 19-68), while mean age at diagnosis of prostate cancer was 60 years (range 47-67). No association was found between energy-adjusted intake of total fat, saturated fat, mono-unsaturated fat or poly-unsaturated fat and the incidence of prostate cancer. Significant positive associations were found for body mass index (BMI) and consumption of hamburgers/meatballs, while no association was found with consumption of frankfurters/sausages and a significant negative association with the weekly number of main meals with meat. A significantly increased risk of prostate cancer was associated with skim milk as compared to whole milk. Milk preference (skim vs. whole) was associated significantly positively with BMI. Our study of a relatively young cohort does not confirm previous case-control and cohort studies suggesting that dietary fat, especially from animal sources, is associated positively with risk of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9398038     DOI: 10.1002/(sici)1097-0215(19971127)73:5<634::aid-ijc4>3.0.co;2-y

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  35 in total

1.  Estimated phytanic acid intake and prostate cancer risk: a prospective cohort study.

Authors:  Margaret E Wright; Phyllis Bowen; Jarmo Virtamo; Demetrius Albanes; Peter H Gann
Journal:  Int J Cancer       Date:  2012-01-24       Impact factor: 7.396

2.  Complementary medicine for prostate cancer: effects of soy and fat consumption.

Authors:  M A Moyad; W A Sakr; D Hirano; G J Miller
Journal:  Rev Urol       Date:  2001

3.  Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population.

Authors:  Yasuhiro Komiya; Hiromasa Tsukino; Hiroyuki Nakao; Yoshiki Kuroda; Hirohisa Imai; Takahiko Katoh
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-23       Impact factor: 4.553

4.  Milk and dairy consumption among men with prostate cancer and risk of metastases and prostate cancer death.

Authors:  Andreas Pettersson; Julie L Kasperzyk; Stacey A Kenfield; Erin L Richman; June M Chan; Walter C Willett; Meir J Stampfer; Lorelei A Mucci; Edward L Giovannucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-02-07       Impact factor: 4.254

5.  Epidemiology of prostate cancer.

Authors:  A C Diokno
Journal:  West J Med       Date:  1998-08

6.  Body mass index affects the diagnosis and progression of prostate cancer in Hispanics.

Authors:  Rosa Negrón; Andrea Vásquez; Mariely Nieves; Lourdes Guerrios; Margarita Irizarry-Ramírez
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

Review 7.  Omega-3 fatty acids, genetic variants in COX-2 and prostate cancer.

Authors:  Adam C Reese; Vincent Fradet; John S Witte
Journal:  J Nutrigenet Nutrigenomics       Date:  2009-09-23

8.  Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies.

Authors:  Michael Huncharek; K Sue Haddock; Rodney Reid; Bruce Kupelnick
Journal:  Am J Public Health       Date:  2009-07-16       Impact factor: 9.308

9.  Metabolic syndrome in sub-Saharan Africa: "smaller twin" of a region's prostatic diseases?

Authors:  Chukwunonso E C C Ejike; Lawrence U S Ezeanyika
Journal:  Int Urol Nephrol       Date:  2008-02-21       Impact factor: 2.370

10.  Height and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.

Authors:  J Ahn; S C Moore; D Albanes; W-Y Huang; M F Leitzmann; R B Hayes
Journal:  Br J Cancer       Date:  2009-06-30       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.